Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis

Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis

Background/Aims Several biologic therapies are approved in Japan to treat moderately to severely active ulcerative colitis (UC), but there are no published comparative efficacy studies in a Japanese population. We compared the efficacy of biologics approved in Japan (adalimumab, infliximab, golimuma...

Full description

Bibliographic Details
Main Authors: Toshifumi Hibi, Isao Kamae, Philippe Pinton, Lyann Ursos, Ryuichi Iwakiri, Greg Hather, Haridarshan Patel
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2021-01-01
Series:Intestinal Research
Subjects:
biologics
colitis, ulcerative
network meta-analysis
efficacy
Online Access:http://www.irjournal.org/upload/pdf/ir-2019-09146.pdf

Internet

http://www.irjournal.org/upload/pdf/ir-2019-09146.pdf

Similar Items